相关实验视频

Updated: Sep 10, 2025

Quantification of Hypopigmentation Activity In Vitro

Quantification of Hypopigmentation Activity In Vitro

Published on: March 6, 2019

针对性疗法诱导的脱色:一个审查

Zhaoyang Wang^1,2, Meng Wang^1,2, Tianyu Wang^1,2

¹Dermatology Hospital of Shandong First Medical University, Jinan, China.

Frontiers in immunology

|August 27, 2025

概括

形状脱色 (VLD) 是针对性癌症治疗的常见副作用,通常表明预后良好. 了解其免疫机制是管理患者生活质量的关键,

科学领域:

结合瘤学,皮肤学和免疫学研究皮肤不良事件.
专注于向治疗,包括免疫检查点抑制剂,BRAF和氨酸激酶抑制剂.

背景情况:

在接受针对癌症和自身免疫性疾病的患者中,白风样脱色是常见的皮肤不良事件.
尽管VLD有时是有利预后的标志物,但它可能会导致严重的心理困扰和影响治疗的坚持.
由各种向药物诱导的VLD背后的免疫病理机制仍然不完全理解.

研究的目的:

探索针对性疗法 (癌症,自身免疫性疾病,疫苗) 诱导的VLD的免疫病理机制.
检查VLD的临床表现,预后影响和管理策略.
突出VLD与改善治疗结果之间的相关性,以及平衡疗效与生活质量的挑战.

主要方法:

综合瘤学,皮肤学和免疫学发现的综合文献综述.
分析与免疫检查点抑制剂,BRAF抑制剂,氨酸激酶抑制剂,疫苗和生物制剂相关的VLD病例.
对临床数据,预后意义和治疗方法的检查.

主要成果:

VLD是与向治疗相关的常见不良事件,通常与积极的治疗反应有关.
包括免疫检查点抑制剂在内的特定向药物与VLD的发展有关.
尽管VLD具有预后价值,但它在患者生活质量管理方面存在挑战.

结论:

了解VLD的免疫病理基础对于优化向治疗结果至关重要.
需要多学科的方法,包括瘤学,皮肤学和免疫学,以有效管理VLD.
需要进一步的研究,以加强在不同临床环境中预防和治疗VLD的策略.

关键词:

药物不良反应自体免疫性颜色的减少黑色细胞针对性药物疫苗的使用

更多相关视频

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Changes in Skin Color: Clinical Perspectives

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...